Post Categories
Novel Coronavirus Testing: Part IV
May 18, 2020
Saliva Testing Accurate, rapid testing for the novel coronavirus (SARS-CoV-2) is crucial to controlling the COVID-19 pandemic. In previous installments of this blog series,…
Novel Coronavirus Testing: Part III
May 6, 2020
Antigen Testing Part I of this series on testing for the novel coronavirus covered the real-time reverse transcription polymerase chain reaction (rRT-PCR) assay, which…
Airborne Coronavirus Discovered in China – Could It Transmit the Novel Coronavirus?
May 6, 2020
Earlier this week, we discussed an aerosolized droplet study conducted by the University of Pennsylvania Perelman School of Medicine and the National Institutes of…
Aerosolized Droplet Study
April 29, 2020
Can the Novel Coronavirus Spread Through Speaking? There are conflicting opinions on whether the novel coronavirus, the virus that causes COVID-19, can be spread…
Novel Coronavirus Testing: Part II
April 27, 2020
Serology Testing “Test, test, test,” was the singular message from the World Health Organization’s Director-General Tedros Adhanom Ghebreyesus during remarks on the coronavirus pandemic…
Novel Coronavirus Testing: Part I
April 20, 2020
Real-Time Reverse Transcriptase Polymerase Chain Reaction Testing is the crucial first step to identifying and treating COVID-19. In the past few months, uncertainty has…
Clinical Trials: Coronavirus Impact and FDA Guidelines
April 13, 2020
The spread of the coronavirus is affecting every facet of the pharmaceutical industry — including clinical trials that are currently underway or scheduled for…
Selecting a CRO for Chronic Disease Drug Development Using Small Molecules
April 1, 2020
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the…
Beauty and the Bacteria: Mechanical Forces in a Multispecies Biofilm Colony
March 30, 2020
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest…
Solanezumab Study Misses the Mark for the Fourth Time
March 17, 2020
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive…
CAR-T and CRISPR Cancer Trial Shows Promise
March 2, 2020
There is new hope for future innovation in the fast-moving field of cancer immunotherapy. Earlier this month, researchers from the University of Pennsylvania and…
Gene Therapy Innovation Strongly Encouraged by FDA with New Guidances
February 10, 2020
On January 28, 2020, the United States Food and Drug Administration (FDA) announced the release of six final guidances on gene therapy manufacturing and the…
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain…
From Cultural Rite to Clinical Trial — Examining the Therapeutic Potential of Mescaline
November 28, 2022
Psychedelics are having a moment, as researchers, startups, and regulators are recognizing the potential of these previously stigmatized compounds for treating mental health disorders….
Researchers Find New Hybrid Virus in Lung Cells
November 21, 2022
Winter is approaching, and with it, flu season. Cases of both influenza (flu) and the respiratory syncytial virus (RSV) tend to experience their peak…
New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
November 16, 2022
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants…
Can UV Light Replace Masks in the Fight Against COVID-19?
November 9, 2022
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous…
Cancer Trials Ask, What’s the Gut Got to Do With It?
November 7, 2022
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
